Landmark Conference Sept. 26-27 at Yale Law School: "The Affordable Care Act at 10: History, Legacy, Challenges"
This unprecedented gathering will reflect on the policy, legal, and political advances and challenges that a decade of the Affordable Care Act has brought us. We will gather the leading scholars and some of the most important players involved in the Affordable Care Act's passage and implementation, including former White House Chief of Staff Rahm Emanuel, former HHS Secretary Kathleen Sebelius, former U.S. Solicitors General Donald Verrilli and Paul Clement, and many others.
"Severe Asthma 2019: Phenotyping in the Clinic and Selection of Therapies Across the Spectrum of Airway Diseases" on Oct. 11
Yale School of Medicine and Yale Center for Asthma and Airway Diseases invite you to attend the upcoming symposium, "Severe Asthma 2019: Phenotyping in the Clinic and Selection of Therapies Across the Spectrum of Airway Diseases", to be held on Friday, October 11, 2019, 8:00 AM - 4:00 PM, at the The Anlyan Center for Medical Research and Education (TAC) in New Haven, CT.
Once-Common Hysterectomy Technique Linked to Worse Uterine Cancer Outcomes
Every year, nearly 700,000 American women have surgery to remove their uterus (hysterectomy) or uterine fibroids (myomectomy). A laparoscopic surgical technique once commonly used in these procedures could be worsening the outcomes for women who have undiagnosed uterine cancer at the time of the procedure, Yale Cancer Center scientists report in the Journal of Clinical Oncology.
HEALTH NOTES: Black and Hispanic Cancer Patients Are Underrepresented in Clinical Trials
A new study has shown that clinical trials for new cancer medications rarely analyze data on safety and effectiveness by race and that black and Hispanic patients are consistently underrepresented among participants.
Yale Cancer Center Researchers Show Adding Radiation After Immunotherapy Improves Survival Time for Patients with Advanced Lung Cancer
The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).
Yale Radiology and Psychiatry Researchers Join with Penn Medicine to Create a New Center to Study Opioid Use Disorders
Opioid use disorder has reached epidemic levels in the United States. Over the last two decades, opioid-related overdose deaths increased by more than 50 percent, with nearly 50,000 in 2018, according to the Centers for Disease Control and Prevention. Researchers from Yale School of Medicine (YSM) and Penn Medicine, which comprises the Perelman School of Medicine at the University of Pennsylvania, have created a new center that focuses on neuroimaging to improve our understanding of opioid use disorders and find new treatments.